Cargando…

S309: SUSTAINED INHIBITION OF PLATELET ACTIVITY AND THROMBOSIS VIA IV AND ORAL ADMINISTRATION OF CS585

Detalles Bibliográficos
Autores principales: Lambert, Sylviane, Rickenberg, Andrew, Dahlof, Bjorn, Bergh, Niklas, Holinstat, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428397/
http://dx.doi.org/10.1097/01.HS9.0000968148.24216.e0
_version_ 1785090459282964480
author Lambert, Sylviane
Rickenberg, Andrew
Dahlof, Bjorn
Bergh, Niklas
Holinstat, Michael
author_facet Lambert, Sylviane
Rickenberg, Andrew
Dahlof, Bjorn
Bergh, Niklas
Holinstat, Michael
author_sort Lambert, Sylviane
collection PubMed
description
format Online
Article
Text
id pubmed-10428397
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104283972023-08-17 S309: SUSTAINED INHIBITION OF PLATELET ACTIVITY AND THROMBOSIS VIA IV AND ORAL ADMINISTRATION OF CS585 Lambert, Sylviane Rickenberg, Andrew Dahlof, Bjorn Bergh, Niklas Holinstat, Michael Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428397/ http://dx.doi.org/10.1097/01.HS9.0000968148.24216.e0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Lambert, Sylviane
Rickenberg, Andrew
Dahlof, Bjorn
Bergh, Niklas
Holinstat, Michael
S309: SUSTAINED INHIBITION OF PLATELET ACTIVITY AND THROMBOSIS VIA IV AND ORAL ADMINISTRATION OF CS585
title S309: SUSTAINED INHIBITION OF PLATELET ACTIVITY AND THROMBOSIS VIA IV AND ORAL ADMINISTRATION OF CS585
title_full S309: SUSTAINED INHIBITION OF PLATELET ACTIVITY AND THROMBOSIS VIA IV AND ORAL ADMINISTRATION OF CS585
title_fullStr S309: SUSTAINED INHIBITION OF PLATELET ACTIVITY AND THROMBOSIS VIA IV AND ORAL ADMINISTRATION OF CS585
title_full_unstemmed S309: SUSTAINED INHIBITION OF PLATELET ACTIVITY AND THROMBOSIS VIA IV AND ORAL ADMINISTRATION OF CS585
title_short S309: SUSTAINED INHIBITION OF PLATELET ACTIVITY AND THROMBOSIS VIA IV AND ORAL ADMINISTRATION OF CS585
title_sort s309: sustained inhibition of platelet activity and thrombosis via iv and oral administration of cs585
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428397/
http://dx.doi.org/10.1097/01.HS9.0000968148.24216.e0
work_keys_str_mv AT lambertsylviane s309sustainedinhibitionofplateletactivityandthrombosisviaivandoraladministrationofcs585
AT rickenbergandrew s309sustainedinhibitionofplateletactivityandthrombosisviaivandoraladministrationofcs585
AT dahlofbjorn s309sustainedinhibitionofplateletactivityandthrombosisviaivandoraladministrationofcs585
AT berghniklas s309sustainedinhibitionofplateletactivityandthrombosisviaivandoraladministrationofcs585
AT holinstatmichael s309sustainedinhibitionofplateletactivityandthrombosisviaivandoraladministrationofcs585